Technical Analysis for ACHV - Achieve Life Sciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 4.71 | 0.64% | 0.03 |
ACHV closed up 0.64 percent on Friday, November 1, 2024, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 7
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Support | Bullish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
MACD Bearish Centerline Cross | Bearish | 0.64% | |
200 DMA Support | Bullish | 0.64% | |
50 DMA Support | Bullish | 0.64% | |
Lower Bollinger Band Touch | Weakness | 0.64% |
Alert | Time |
---|---|
200 DMA Support | about 19 hours ago |
Possible NR7 | about 19 hours ago |
Possible Inside Day | about 19 hours ago |
50 DMA Support | about 22 hours ago |
200 DMA Resistance | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.98 |
52 Week Low | 3.03 |
Average Volume | 96,484 |
200-Day Moving Average | 4.67 |
50-Day Moving Average | 4.67 |
20-Day Moving Average | 4.92 |
10-Day Moving Average | 4.77 |
Average True Range | 0.17 |
RSI (14) | 45.36 |
ADX | 18.58 |
+DI | 17.29 |
-DI | 23.19 |
Chandelier Exit (Long, 3 ATRs) | 4.76 |
Chandelier Exit (Short, 3 ATRs) | 5.12 |
Upper Bollinger Bands | 5.26 |
Lower Bollinger Band | 4.58 |
Percent B (%b) | 0.2 |
BandWidth | 13.87 |
MACD Line | -0.01 |
MACD Signal Line | 0.04 |
MACD Histogram | -0.046 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.82 | ||||
Resistance 3 (R3) | 4.80 | 4.76 | 4.80 | ||
Resistance 2 (R2) | 4.76 | 4.73 | 4.76 | 4.79 | |
Resistance 1 (R1) | 4.73 | 4.71 | 4.75 | 4.75 | 4.79 |
Pivot Point | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 |
Support 1 (S1) | 4.66 | 4.66 | 4.68 | 4.68 | 4.63 |
Support 2 (S2) | 4.62 | 4.64 | 4.62 | 4.63 | |
Support 3 (S3) | 4.59 | 4.62 | 4.62 | ||
Support 4 (S4) | 4.61 |